Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Israeli medical company seeks investment for its Ophthalmic project.
|Total value of the target||N/A|
|Expected target net rate of return after deducting all taxes and fees||N/A|
|Validity period of pending order||365|
Senior Associate, International Business Advisory
|Project highlights||Ophthalmic drug delivery - eye drops treatment - precilinical stage|
The Israeli medical company is a joint venture, which authorizes the use of non-invasive local drug delivery technology, which is used to treat posterior ocular diseases by eye drops instead of current drug delivery methods (such as intravitreal injection). The platform technology can also be used for eye treatment. The project is currently in the preclinical stage of the development of a few candidate products. The company seeks investment for this project.
Enquire for more information about our services, and how we can help solve challenges for your organizationContact Us